MARASCIO, Nadia
 Distribuzione geografica
Continente #
NA - Nord America 923
EU - Europa 435
AS - Asia 39
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.401
Nazione #
US - Stati Uniti d'America 895
IT - Italia 255
SE - Svezia 67
GB - Regno Unito 47
CA - Canada 28
DE - Germania 22
FR - Francia 8
IN - India 7
IR - Iran 7
MT - Malta 7
RO - Romania 7
ES - Italia 5
FI - Finlandia 4
PK - Pakistan 4
JP - Giappone 3
LV - Lettonia 3
PH - Filippine 3
TR - Turchia 3
AM - Armenia 2
CL - Cile 2
HK - Hong Kong 2
HR - Croazia 2
MN - Mongolia 2
NL - Olanda 2
PL - Polonia 2
CH - Svizzera 1
CN - Cina 1
EU - Europa 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
PE - Perù 1
PT - Portogallo 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 1.401
Città #
Chandler 180
Lawrence 92
Princeton 92
Wilmington 55
Chicago 47
London 42
Ashburn 35
Rome 29
Ottawa 27
Des Moines 22
Crotone 20
Catanzaro 16
Norwalk 13
Milan 8
Los Angeles 7
St Louis 7
Assago 6
Maryland Heights 6
Palermo 6
Redwood City 6
Casalnuovo di Napoli 5
Hanover 5
Lyon 5
New York 5
Florence 4
Helsinki 4
Monheim 4
Pisa 4
Pune 4
Reggio Calabria 4
West Jordan 4
Cosenza 3
Genoa 3
Lahore 3
Montegiordano 3
Monza 3
Naples 3
Padova 3
Redmond 3
Rende 3
San Francisco 3
Voghera 3
Zejtun 3
Agrigento 2
Ardea 2
Badalona 2
Barcelona 2
Benevento 2
Boardman 2
Borås 2
Casoria 2
Castelfiorentino 2
Castelliri 2
Cerignola 2
Cernusco sul Naviglio 2
Fayetteville 2
Fiumicino 2
Labico 2
Melita 2
Napoli 2
Orta 2
Pizzo 2
Riga 2
San Biagio di Callalta 2
Senigallia 2
Settingiano 2
Tokyo 2
Turin 2
Verona 2
Amman 1
Bari 1
Beijing 1
Bisceglie 1
Boydton 1
Brindisi 1
Carini 1
Cassano Allo Ionio 1
Catania 1
Clearwater 1
Cologna Veneta 1
Constanța 1
Crawfordsville 1
Dearborn 1
Denver 1
Gradisca D'isonzo 1
Ilsan 1
Islamabad 1
Kastav 1
Kuwait City 1
La Canada Flintridge 1
Laurel 1
Lima 1
Lisbon 1
Manila 1
Meggen 1
Modugno 1
Muggia 1
Nagold 1
North Bergen 1
Pacoima 1
Totale 883
Nome #
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 84
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 33
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 32
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 32
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 30
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 28
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 28
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 27
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 27
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 27
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes 26
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 25
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 25
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 25
Citrus bergamia: Kinetics of Antimicrobial Activity on Clinical Isolates 24
Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study 23
31st International papillomavirus conference Cape Town, 28 Febbraio - 4 Marzo 2017. 23
EVALUATION OF IL-35, AS A POSSIBLE BIOMARKER FOR FOLLOW-UP AFTER THERAPY, IN CHRONIC HUMAN SCHISTOSOMA INFECTION 22
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 22
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 22
Diagnosis and follow-up of Bartonella henselae infection in the spleen of an immunocompetent patient by real-time quantitative PCR 21
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 21
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 20
SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion 20
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 19
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 19
Chapter: Next-generation sequencing and microbiome evaluation: Molecular microbiology and its impact on human health 19
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4 18
Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients 18
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure. 18
Aspetti clinici ed epidemiologici dell’infezione da genotipo 4 di HCV 17
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 16
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 16
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy 16
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 16
Molecular characterization of Schistosoma infections in African migrants: Identification of a Schistosoma haematobium-bovis hybrid in bladder biopsies 16
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 16
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 15
Data presentation HCV virology 15
Outcome of hbv screening and vaccination in a migrant population in southern italy 14
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 14
Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients. 14
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 13
Six years genotype distribution of Human Papillomavirus in Calabria Region, Southern Italy: a retrospective study. 13
Diagnosis and follow-up of Bartonella henselae infection in the spleen of an immunocompetent patient by real-time quantitative PCR 13
Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy). 13
Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing. 13
Changing epidemiology of hepatitis C in Italy: a population-based survey in a historically high endemic area 13
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 13
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 12
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota 12
Efflux Pump AdeABC Assessment in Acinetobacter baumannii Strains Isolated in a Teaching Hospital 12
Diagnosis and follow up of Bartonella henselae infection in the spleen of an immunocompetent patient by Real-Time Quantitative Polymerase Chain Reaction 12
Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy 12
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy 12
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 11
Cat-Scratch Diseases (CSD) con coinvolgimento splenico multifocale in paziente immunocompetente: contributo della diagnosi molecolare 11
Ultra-deep sequencing and bioinformatics approach to detect natural resistance-associated variants in DAA-naïve HCV positive patients 11
Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 10
Virus-Free Synthesis of a Hepatitis C Virus p7 cDNA through a Three-Steps Polymerase Chain Reaction 10
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 10
Neurobrucellosi sintomatica, PCR positiva, wright negativa, coltura negativa 10
Update on HPV epidemiology in Calabria Region, Southern Italy. 10
SOLUBLE CD14 SUBTYPE - A NEW BIOMARKER IN PREDICTING OUTCOME OF CRITICALLY ILL SEPTIC PATIENTS: AN OBSERVATIONAL PROSPECTIVE STUDY. 9
RICONOSCIMENTO MOLECOLARE DEL DASABUVIR, TEGOBUVIR E SETROBUVIR NEL DOMINIO PALM I DELLA POLIMERASI DEL VIRUS DELL’EPATITE C, IN PRESENZA DELLA MUTAZIONE NATURALE 316N 9
Structural analysis against HCV polymerase in presence of natural resistance-associated substitutions in HCV isolates from DAA-naïve patients 9
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 8
ROLE OF TREG, BREG AND OTHER CYTOKINE SETS IN HOST PROTECTION AND IMMUNOPATHOLOGY DURING HUMAN LEISHMANIASIS: ARE THEY POTENTIAL VALUABLE MARKERS IN CLINICAL SETTINGS AND VACCINE EVALUATION? 8
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 8
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 8
Update on different aspects of HCV variability: focus on NS5B polymerase 8
Incremento della prevalenza di infezione da virus dell'epatite c di genotipo 4 in Calabria 8
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients 8
Is neutrophil gelatinase associated lipocalin a marker of renal impairment in HCV infection? 8
Prevalenza di HCV3 ed HCV4 nella nuova era degli antivirali ad azione diretta (DAA) 8
Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry 7
Gut Inflammation and Immunity: What Is the Role of the Human Gut Virome? 7
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals 7
Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology) 7
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions. 7
Real-life 3D therapy failure: analysis of NS5A 93H RAS plus 108K polymorphism in complex with ombitasvir by molecular modeling 7
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy? 7
Is neutrophil gelatinase associated lipocalin a marker of renal impairment in HCV infection? 7
Identification of pmrB Mutations as Putative Mechanism for Colistin Resistance in A. baumannii Strains Isolated after In Vivo Colistin Exposure. 7
Founder effect of NS3 variant Q80K in HCV1a infected patients in Italy 7
Valutazione della funzione renale nei pazienti con infezione cronica da HCV in trattamento con DAA (directly-acting-antivirals): proposta collaborativa del progetto calabrese “SINERGIE”. 7
Resistance-associated and fitness-associated substitutions on NS3, NS5A and NS5B genes in real-life HCV positive patient failed to 3D therapy. 7
MOLECULAR CHARACTERIZATION AND CLUSTER ANALYSIS OF SARS-COV-2 VIRAL ISOLATES IN KAHRAMANMARAŞ CITY, TURKEY: THE DELTA VOC WAVE WITHIN ONE MONTH 6
Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice 6
OMIC INSIGHTS INTO VARIOUS CEFTAZIDIME-AVIBACTAM-RESISTANT KLEBSIELLA PNEUMONIAE ISOLATES FROM TWO SOUTHERN ITALIAN REGIONS 6
The impact of a vaccination campaign against hepatitis B on the further decrease of hepatitis B virus infection in a southern Italian town over 14 years. 6
Molecular identification of Bartonella quintana infection using species-specific real-time PCR targeting transcriptional regulatory protein (bqtR) gene. 6
Evolution of glomerular filtration rates an neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals 6
Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients 6
Presepsin: a possible sepsis marker for critically ill patients? 6
Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives” 6
Does the Human Gut Virome Contribute to Host Health or Disease? 5
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson's disease model 5
Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression 5
Update on epidemiology of HCV in Italy: focus on the Calabria Region 5
Totale 1.466
Categoria #
all - tutte 21.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 0 0 0 0 30 8 9 12 11 3 10 28
2020/2021125 8 0 9 7 15 30 27 8 13 7 0 1
2021/2022269 3 1 0 70 5 2 24 59 26 22 53 4
2022/2023639 196 59 17 54 41 44 23 28 75 33 55 14
2023/2024381 75 65 20 30 27 86 12 24 15 20 7 0
Totale 1.525